HKD 1.1
(-0.9%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -191.57 Million CNY | -167.1% |
2022 | 285.52 Million CNY | 79.8% |
2021 | 158.8 Million CNY | -28.03% |
2020 | 220.63 Million CNY | 245.28% |
2019 | 63.9 Million CNY | -8.06% |
2018 | 69.5 Million CNY | 118.52% |
2017 | 31.8 Million CNY | 429.95% |
2016 | -9.63 Million CNY | 62.48% |
2015 | -25.69 Million CNY | -1173.55% |
2014 | -2.01 Million CNY | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 FY | -191.57 Million CNY | -167.1% |
2023 Q2 | 321.87 Million CNY | 12.73% |
2023 Q4 | -191.57 Million CNY | -159.52% |
2022 Q4 | 285.52 Million CNY | 21.91% |
2022 FY | 285.52 Million CNY | 79.8% |
2022 Q2 | 234.2 Million CNY | 47.48% |
2021 Q2 | 138.46 Million CNY | -37.24% |
2021 FY | 158.8 Million CNY | -28.03% |
2021 Q4 | 158.8 Million CNY | 14.69% |
2020 Q2 | 210.39 Million CNY | 229.24% |
2020 Q4 | 220.63 Million CNY | 4.87% |
2020 FY | 220.63 Million CNY | 245.28% |
2019 FY | 63.9 Million CNY | -8.06% |
2019 Q4 | 63.9 Million CNY | 0.0% |
2018 FY | 69.5 Million CNY | 118.52% |
2017 Q2 | -17.44 Million CNY | -80.94% |
2017 Q4 | 31.8 Million CNY | 282.36% |
2017 FY | 31.8 Million CNY | 429.95% |
2016 FY | -9.63 Million CNY | 62.48% |
2016 Q4 | -9.63 Million CNY | 0.0% |
2015 FY | -25.69 Million CNY | -1173.55% |
2014 FY | -2.01 Million CNY | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Uni-Bio Science Group Limited | -76.36 Million HKD | -150.86% |
CK Life Sciences Int'l., (Holdings) Inc. | 5.26 Billion HKD | 103.637% |